Centrus Energy Corp vs BIO-TECHNE Corp — how do they compare? Centrus Energy Corp trades at $171.24 (market cap $3.08B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 3.6× Centrus Energy Corp's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.
| LEU | TECH | |
|---|---|---|
Market Cap | $3.08B | $11.16B |
Sector | Energy | Health |
52-Week High | $436.00 | $72.12 |
52-Week Low | $146.61 | $43.31 |
Enterprise Value | $2.39B | $11.24B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →